Subjective experience with antipsychotics: quantitative evaluation

Authors

  • M. Barberá Psychiatry Service, Hospital La Fe, Valencia (Spain)
  • J. Sanjuán Hospital Clínico, Facultad de Medicina, Universidad de Valencia (Spain)
  • M. Munárriz Centro de Salud Mental de Burriana, Castellón (Spain)
  • E. Novella Hospital Clínico, Facultad de Medicina, Universidad de Valencia (Spain)
  • C. Santiago Centro de Salud Mental de Burriana, Castellón (Spain)
  • M. Simó Centro de Salud Mental de Burriana, Castellón (Spain)

Keywords:

Subjective experience, Side effects, Antipsychotis, Psychosis, Schizophrenia, Rating-Scales

Abstract

Introduction. The subjective experience of psychotic patients with neuroleptics has been the purpose of many studies, considering its importance in treatment adherence, quality of life and outcome. Many authors have developed measurement instruments applicable in everyday clinical practice. The scale objectives defer in hues, but have the subjective perspective in common.

Method. Questionnaires designed for evaluating subjective experience with antipsychotics, appearing in PUBMED during the last 40 years, have been collected.

Results. Ten scales for evaluating the subjective experience with antipsychotics: NDS, DRI, DAI-30, DAI-10, ROMI, SWN, SWN (short version), MARS, ANT and PETiT, were found. Their advantages and limitations have been analyzed.

Conclusions. We have cheked out that the contents of each scale do not overlap. It is proposed to differentiate between «dysphoria response to neuroleptics» as an acute effect and the «subjective experience» as complex effect of long term compliance.

Downloads

Published

2006-09-01

How to Cite

Barberá, M., et al. “Subjective Experience With Antipsychotics: Quantitative Evaluation”. Actas Españolas De Psiquiatría, vol. 34, no. 5, Sept. 2006, pp. 287-94, https://actaspsiquiatria.es/index.php/actas/article/view/1313.

Issue

Vol. 34 No. 5 (2006)

Section

Original